Coordinated Mother and Child Action
Last updated on 19 May 2025
The essential
- The “historic” Mother and Child Group focused mainly on HIV (AC44).
- The Coordinated Mother and Child Action (AC ME), established in 2024, aims to cover the entire scope of the ANRS MIE while meeting its scientific research priorities.
- It is interdisciplinary and cross-thematic in nature, working across and complementing other coordinated action thematic, specifically targeting vertical transmission, mothers, children and adolescents.
Focus and missions
The Coordinated Mother and Child Action has three main areas:
- Fundamental science
- Clinical research
- Public health
Its main tasks include:
- Promoting research projects dedicated to pregnant women, children and adolescents.
- Reflection on the inclusion (or exclusion) of these populations in clinical studies and trials.
- Implementation of cross-functional and structural projects with a high-impact.
Finally, the Coordinated Mother and Child Action plays a key role as an interface with the mother-child working groups of other ACs, fostering a coordinated and integrated approach.
Co-Chair
Ndeye Ramatoulaye DIAGNE GUEYE
Univ. Thies, Dakar
Pierre FRANGE
Hôpital Necker, Univ. Paris Cité
Valériane LEROY
CERPOP, Univ. Toulouse
Chair of the Scientific Advisory Board
Albert FAYE
Hôpital Robert Debré, Univ. Paris Cité
Board members
Management and supervision by the ANRS MIE Clinical Research Vigilance Department
Alpha DIALLO, head of the pharmacovigilance department
(ANRS MIE)
Christelle PAUL, operations manager
(ANRS MIE)
Alice DUGAT, pharmacovigilance officer
(ANRS MIE)
Chantal DAUGAN, assistant
(ANRS MIE)
Actualités
The second plenary meeting will take place on 2 June 2025.
International network: a new PRISME is emerging in Togo
The ANRS MIE and its French and Togolese partners are laying the foundations of a PRISME platform in Togo, an ambitious and unifying partnership.
28 May 2025